- Category
- Micro (2022-23)
- Udyam number
- UDYAM-RJ-02-0004815

About Wave Pharmaceuticals Limited
Data last updated:
Wave Pharmaceuticals Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1997PLC088998. Its GSTIN is 07AAACW2771M2ZY (Delhi). The company holds 6 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.95 Cr. It is led by directors including Nikhil Gupta and Sanjay Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 6 Oberoi Appartments, 2 Sham Nath Marg Civil Lines, Delhi, India – 110054.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.93 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹8.58 Lakh (net margin 4.4%) and EBITDA of -₹54.4 Lakh (EBITDA margin -28.2%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 267% over five years.
The company is associated with 1 brand: Wave Pharmaceuticals Limited. As per MCA filings, the company has satisfied charges of ₹50.65 Lakh on record.
Wave Pharmaceuticals Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-02-0004815). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wavepharma.in.
Company details
CIN history
Wave Pharmaceuticals has one previous CIN (Corporate Identification Number): L24231DL1997PLC088998. The current CIN is U24231DL1997PLC088998, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231DL1997PLC088998 | Current |
| L24231DL1997PLC088998 | Previous |
Recognitions & Rankings of Wave Pharmaceuticals
Contact details
Wave Pharmaceuticals Limited's registered office is in Delhi, Delhi. Its website is wavepharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 6 Oberoi Appartments, 2 Sham Nath Marg Civil Lines, Delhi, India – 110054
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Wave Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Wave Pharmaceuticals operates one associated brand: Wave Pharmaceuticals Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Development and manufacturing of pharmaceutical products globally by Wave Pharmaceuticals Limited. | wavepharma.in |
Financials of Wave Pharmaceuticals Limited
FY 2025 filings availableWave Pharmaceuticals Limited reported revenue of ₹1.93 Cr (up 50% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 267% over five years, including 50% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.93 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹54.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -28.2% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wave Pharmaceuticals Limited, buy the company report.
Board of directors of Wave Pharmaceuticals Limited
Wave Pharmaceuticals has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Gupta Also directs: Iwave Pharmaceuticals Private Limited | Director | 28 Jan 2017 | 9 Years 9 Months | Current |
| Sanjay Gupta Also directs: Iwave Pharmaceuticals Private Limited | Director | 28 Jan 2017 | 9 Years 9 Months | Current |
| Sarita Gupta | Director | 10 Feb 2018 | 8 Years 9 Months | Current |
Auditor
Wave Pharmaceuticals Limited is audited by KSMC & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KSMC & ASSOCIATES | FY 2023 | 003565N |
Shareholding
The shareholding of Wave Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Wave Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Mar 2003 | 90037931 | Canara Bank | ₹25 Lakh | Satisfied | |
| 12 Dec 2001 | 90036942 | Punjab National Bank | ₹25.65 Lakh | Satisfied |
To see the full charge records of Wave Pharmaceuticals Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Wave Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wave Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wave Pharmaceuticals has 6 GST registrations: 4 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACW2771M2ZY | Delhi | Active | 03 May 2018 |
| 24AAACW2771M1Z3 | Gujarat | Active | 25 Apr 2019 |
| 05AAACW2771M1Z3 | Uttarakhand | Active | 07 Sep 2019 |
| 08AAACW2771M1ZX | Rajasthan | Active | 23 Feb 2021 |
To see the full GST registrations and return filing status of Wave Pharmaceuticals Limited, buy the company report.
Recent activity
Wave Pharmaceuticals Limited has 10 board changes on record since 2017: 3 appointments and 7 cessations. The latest: Nikhil Gupta ceased to be Additional Director on 29 Sep 2018.
6 earlier events are in the company report.
Frequently asked questions
Wave Pharmaceuticals is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 1997 (29+ years old) and is registered under CIN U24231DL1997PLC088998.
Wave Pharmaceuticals has 3 current directors:
- Nikhil Gupta - Director
- Sanjay Gupta - Director
- Sarita Gupta - Director
The latest financial statements of Wave Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Wave Pharmaceuticals is 07AAACW2771M2ZY, registered in Delhi. The company has 6 GST registrations in all, of which 4 are active and 2 are cancelled or inactive. Other active GSTINs include 24AAACW2771M1Z3 (Gujarat), 05AAACW2771M1Z3 (Uttarakhand), 08AAACW2771M1ZX (Rajasthan).
The CIN (Corporate Identification Number) of Wave Pharmaceuticals is U24231DL1997PLC088998. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wave Pharmaceuticals was incorporated on 08 August 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.
Nikhil Gupta ceased to be Additional Director on 29 Sep 2018. Sanjay Gupta ceased to be Additional Director on 29 Sep 2018. Sarita Gupta ceased to be Additional Director on 29 Sep 2018. Wave Pharmaceuticals has 10 board changes on record in total.
Yes, Wave Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-02-0004815).
Wave Pharmaceuticals can be reached through the website wavepharma.in. Its registered office is in Delhi, India.
The registered office of Wave Pharmaceuticals is at B – 6 Oberoi Appartments, 2 Sham Nath Marg Civil Lines, Delhi, India – 110054.

